Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation

The linear ubiquitin assembly complex (LUBAC) is an essential component of the innate and adaptive immune system. Modification of cellular substrates with linear polyubiquitin chains is a key regulatory step in signal transduction that impacts cell death and inflammatory signaling downstream of various innate immunity receptors. Loss-of-function mutations in the LUBAC components HOIP and HOIL-1 yield a systemic autoinflammatory disease in humans, whereas their genetic ablation is embryonically lethal in mice. Deficiency of the LUBAC adaptor protein Sharpin results in a multi-organ inflammatory disease in mice characterized by chronic proliferative dermatitis (cpdm), which is propagated by TNFR1-induced and RIPK1-mediated keratinocyte cell death. We have previously shown that caspase-1 and -11 promoted the dermatitis pathology of cpdm mice and mediated cell death in the skin. Here, we describe a reciprocal regulation of caspase-1 and LUBAC activities in keratinocytes. We show that LUBAC interacted with caspase-1 via HOIP and modified its CARD domain with linear polyubiquitin and that depletion of HOIP or Sharpin resulted in heightened caspase-1 activation and cell death in response to inflammasome activation, unlike what is observed in macrophages. Reciprocally, caspase-1, as well as caspase-8, regulated LUBAC activity by proteolytically processing HOIP at Asp-348 and Asp-387 during the execution of cell death. HOIP processing impeded substrate ubiquitination in the NF-κB pathway and resulted in enhanced apoptosis. These results highlight a regulatory mechanism underlying efficient apoptosis in keratinocytes and provide further evidence of a cross-talk between inflammatory and cell death pathways.

The linear ubiquitin assembly complex (LUBAC) is an essential component of the innate and adaptive immune system. Modification of cellular substrates with linear polyubiquitin chains is a key regulatory step in signal transduction that impacts cell death and inflammatory signaling downstream of various innate immunity receptors. Loss-of-function mutations in the LUBAC components HOIP and HOIL-1 yield a systemic autoinflammatory disease in humans, whereas their genetic ablation is embryonically lethal in mice. Deficiency of the LUBAC adaptor protein Sharpin results in a multi-organ inflammatory disease in mice characterized by chronic proliferative dermatitis (cpdm), which is propagated by TNFR1-induced and RIPK1-mediated keratinocyte cell death. We have previously shown that caspase-1 and -11 promoted the dermatitis pathology of cpdm mice and mediated cell death in the skin. Here, we describe a reciprocal regulation of caspase-1 and LUBAC activities in keratinocytes. We show that LUBAC interacted with caspase-1 via HOIP and modified its CARD domain with linear polyubiquitin and that depletion of HOIP or Sharpin resulted in heightened caspase-1 activation and cell death in response to inflammasome activation, unlike what is observed in macrophages. Reciprocally, caspase-1, as well as caspase-8, regulated LUBAC activity by proteolytically processing HOIP at Asp-348 and Asp-387 during the execution of cell death. HOIP processing impeded substrate ubiquitination in the NF-B pathway and resulted in enhanced apoptosis. These results highlight a regulatory mechanism underlying efficient apoptosis in keratinocytes and provide further evidence of a cross-talk between inflammatory and cell death pathways.
The linear ubiquitin assembly complex (LUBAC) 3 is an E3 ligase that has emerged as a critical regulator of both innate (1)(2)(3)(4) and adaptive immunity (5)(6)(7). LUBAC forms a tripartite oligomeric complex in cells and is composed of the catalytic E3 ligase HOIP, an auxiliary E3 HOIL-1, and the adaptor Sharpin. LUBAC is unique in its ability to assemble linear Met-1-linked polyubiquitin chains (Met1-Ub) that do not utilize any internal lysine residues; instead, the terminal carboxyl group of Gly-76 in the proximal ubiquitin forms a peptide bond with the ␣-amino group of a distal ubiquitin (8). In the context of innate immunity signaling, Met1-Ub chains act cooperatively with Lys-63-linked polyubiquitin (Lys63-Ub), often synthesized by the cellular inhibitors of apoptosis (cIAP) proteins cIAP1 and cIAP2 E3 ligases, to promote NF-B activation and curb cell death (9). RIPK1 and the IKK regulatory subunit NEMO are two well-described ubiquitinated substrates in the TNF receptor 1 (TNFR1) pathway that are modified with both Met1-Ub and Lys63-Ub, which act to scaffold downstream signaling factors and facilitate IKK␣/␤ kinase activation (10,11). Suboptimal Met1-Ub or Lys63-Ub of these substrates promotes caspase-8 -driven apoptosis, or RIPK1/RIPK3/MLKL-driven necroptosis when caspases are inhibited (9,12). Both RIPK1 and caspase-8 have also been reported to be modified with Met1-Ub during necroptosis (13), although the functional consequence of their modification remains poorly understood.
LUBAC is essential for homeostasis and health in both mice and humans. Hypomorphic and/or loss-of-function mutations in HOIP (RNF31) or HOIL (RBCK1) have been identified in patients with a life-threatening systemic disease characterized by recurrent bacterial and viral infections, autoinflammation, amylopectinosis, and lymphangiectasia (14 -16). Interestingly, loss-of-function mutations in the Met1-Ub-specific deubiquitinase OTULIN yield an autoinflammatory disease with strikingly similar clinical features (17)(18)(19). Of note, the seemingly paradoxical occurrence of autoinflammation, heightened susceptibility to infection, and autoimmunity in these patients has been attributed to the cell type-specific roles for LUBAC and OTULIN (20). In mice, deletion of either HOIP (21) or HOIL-1 (22) results in embryonic lethality at day 10.5 due to TNFdriven endothelial cell death. On the other hand, Sharpin-deficient mice are viable but develop a multi-organ inflammatory disease characterized primarily by chronic proliferative dermatitis (cpdm) (23). Whereas TNF-mediated cell death of keratinocytes is key in disease pathogenesis in the cpdm mice (24 -26), we have previously shown that hyperactivation of the Nlrp3-caspase-1 inflammasome is an important initiating sig- cro ARTICLE nal that promotes downstream apoptotic and necroptotic cell death driving skin pathology (27). However, how LUBAC controlled caspase-1 activity was unclear. Further, how cells regulated LUBAC activity for the proper execution of cell death was incompletely characterized.
Here, we show that caspase-1 is a novel target of Met1-Ub by LUBAC and that LUBAC-deficient keratinocytes display enhanced caspase-1 activation. Upon activation, caspase-1 and -8 cleaved HOIP, which promotes cell death and limits NF-Bdependent gene expression. Our results describe two novel checkpoints in the regulation of inflammatory cell death pathways in keratinocytes.

LUBAC deficiency in keratinocytes promotes caspase activation
Sharpin deficiency in mice triggers an inflammatory skin disease that is driven by Nlrp3-caspase-1-mediated IL-1␤ production (27,28). We and others found that Sharpin-deficient bone marrow-derived macrophages had attenuated caspase-1 activation and IL-1␤ secretion in response to inflammasome triggers (3,27). However, it is now well-appreciated that the Met1-Ub machinery possesses distinct functional roles in different cell types (14,15,17,20). Because keratinocytes are thought to be the primary pathogenic cell type involved in cpdm skin disease (24), we sought to investigate the role of LUBAC in controlling caspase-1 activity in keratinocytes. We generated Sharpin-depleted HaCaT keratinocytes using shRNA and investigated their response to UVB irradiation, a known inducer of the Nlrp1-caspase-1 inflammasome in the skin (29,30). Sharpin-depleted cells displayed enhanced cleavage of caspase-1, -3, and -8 compared with control cells (Fig.  1A). Using a bioluminescent reporter of caspase-1 activity, we confirmed that Sharpin-depleted keratinocytes had hyperactive caspase-1 in response to UVB compared with pLKO.1 control knockdown cells (Fig. 1B). Knockdown of HOIP likewise rendered cells hyperresponsive to UVB-induced caspase activation ( Fig. 1, A and B), suggesting that LUBAC is required to limit caspase activity in keratinocytes.

Caspase-1 is a putative linear ubiquitin substrate
To examine the molecular interaction dynamics between LUBAC components and caspase-1, we next performed co-immunoprecipitation experiments in HaCaT keratinocytes at steady state or following UVB irradiation. We observed constitutive binding between HOIP and caspase-1 at steady state, which decreased 6 h post-UVB (Fig. 1C). Conversely, Sharpin recruitment to the complex was enhanced by UVB irradiation (Fig. 1D). HOIP binding to caspase-1 was validated in HEK293T cells (Fig. 1D). Notably, HOIL-1 co-immunoprecipitated with caspase-1 solely in the presence of HOIP, suggesting indirect binding (Fig. 1D). Given this interaction between LUBAC and caspase-1, we wondered whether LUBAC targeted caspase-1 for Met1-Ub. Indeed, using immunoprecipitation under denaturing conditions, we observed that caspase-1 was readily modified with Met1-Ub chains when co-expressed with HOIL-1 and WT HOIP, but not a catalytically inactive (E3-dead) C885A HOIP mutant (Fig. 1E). To confirm the specificity of this mod-ification, we examined the effect of expressing OTULIN, a Met1-Ub-specific deubiquitinase, on the caspase-1 ubiquitination signal. Indeed, expression of WT OTULIN, but not a catalytically suppressed W96R OTULIN mutant (31), led to a complete ablation of the caspase-1 Met1-Ub signal (Fig. 1F,  compare lanes 6 and 7). To identify the caspase-1 domain targeted by LUBAC, we generated caspase-1 deletion variants and examined their linear ubiquitination. Such domain mapping revealed that caspase-1 is targeted for Met1-Ub within its CARD (Fig. 1G). To identify the lysine residue modified by Met1-Ub, we systematically mutated all lysine residues within the caspase-1 CARD to alanine. However, whereas individual Lys 3 Ala mutation reduced the Met1-Ub signal, none led to its complete abrogation (Fig. 1H), suggesting that either multiple sites are targeted or there is compensation following mutation of the bona fide target site. Collectively, these data demonstrate that LUBAC inhibits caspase-1 function in keratinocytes and can target its CARD with Met1-Ub in an overexpression system.

Caspase-1 reciprocally targets HOIP for proteolytic cleavage
To address whether there may exist a reciprocal regulation of LUBAC function by caspases, we next monitored the expression of LUBAC components following UVB irradiation. Whereas Sharpin and HOIL-1 proteins displayed no changes, as assessed by immunoblot analysis, a lower-molecular-weight HOIP band appeared at 4 h post-UVB irradiation ( Fig. 2A). This band dose-dependently disappeared upon treatment with the caspase-1-selective inhibitor YVAD-fmk ( Fig. 2A), suggesting a caspase-1-mediated cleavage event. To validate this observation in an in vivo setting, we examined HOIP status in skin homogenates from cpdm mice, which we previously showed to display hyperactivation of caspase-1 (27). We observed similar putative HOIP cleavage fragments (Fig. 2B, arrows) that were not present in either WT mice or cpdm mice deficient in caspase-1/11 (cpdm; Ice Ϫ/Ϫ ) (Fig. 2B). To determine whether HOIP was a direct caspase-1 substrate, we generated in vitro transcribed and translated (ITT) HOIP and incubated the product with increasing doses of recombinant caspase-1, with pro-IL-1␤ serving as a control for caspase-1 activity. Indeed, recombinant caspase-1 dose-dependently cleaved ITT HOIP (Fig.  2C). Transfected active caspase-1 was likewise capable of cleaving HOIP in HEK293T cells (Fig. 2D). These data identify HOIP as a novel caspase-1 substrate.

HOIP is cleaved at Asp-348 and Asp-387 by caspase-1 and -8 in apoptotic keratinocytes
UVB irradiation of keratinocytes activates both the NLRP1caspase-1 inflammasome and the intrinsic mitochondrial apoptosis pathway (29,30,32). We previously noted the concurrent activation of both inflammatory and apoptotic caspases in inflamed cpdm skin (27). To test whether HOIP cleavage is a common feature during cell death, we treated HaCaT keratinocytes with TNF ϩ cycloheximide (CHX) to trigger extrinsic apoptosis. Similar to UVB irradiation, we observed a kinetic processing of HOIP that was blocked with the pan-caspase inhibitor Z-VAD-fmk, whereas both HOIL-1 and Sharpin remained unaffected (Fig. 3A). As caspase-1 is generally not

Regulation of caspase-1 and LUBAC activity in keratinocytes
involved in apoptosis in most cell types, we examined HOIP cleavage in THP-1 monocytes in response to both inflammasome and apoptotic triggers. Interestingly, activation of caspase-1 downstream of the NLRP3, AIM2, and NLRC4 inflammasomes via ATP, poly(dA:dT), and flagellin, respectively, in LPS-primed cells did not trigger HOIP cleavage Lysates were subject to anti-caspase-1 immunoprecipitation, followed by immunoblot analysis. Data are representative of three independent experiments. D, HEK293T cells were transfected with equal amounts of the indicated plasmids. 24 h post-transfection, lysates were harvested and subjected to FLAG M2 immunoprecipitation and immunoblot analysis. E-H, as in D, but cells were lysed in 1% SDS denaturing lysis buffer, followed by dilution to 0.1% SDS for immunoprecipitation with either FLAG M2 affinity gel (E, G, and H) or anti-caspase-1 (F). Data are representative of two independent experiments, except H, which was performed once. 3B). Induction of apoptosis by UVB, TNF ϩ BV6, or etoposide, however, resulted in HOIP cleavage concurrent with caspase-8 activation (Fig. 3B). HOIP processing is thus a common consequence of apoptosis; however, the involvement of caspase-1 seems limited to keratinocytes.

Regulation of caspase-1 and LUBAC activity in keratinocytes
These data suggest that other caspases are involved in HOIP cleavage. We therefore tested a panel of recombinant caspases for their ability to directly cleave ITT HOIP. Interestingly, caspase-8 and, to a lesser extent, caspase-6 were also capable of cleaving HOIP, generating a fragment that was slightly smaller than that processed by caspase-1 (Fig. 3C). Pretreatment of HaCaT cells with either the caspase-1 inhibitor YVAD-fmk or the caspase-8 inhibitor IETD-fmk was sufficient to block HOIP cleavage in keratinocytes treated with either TNF ϩ CHX or UVB (Fig. 3D). Using shRNA, we stably depleted HaCaT cells of either caspase-1, -3, or -8 and found that loss of any of these caspases attenuated HOIP processing in response to UVB irradiation (Fig. 3E).
Given the size and relative orientation of the cleavage fragments when blotting for either the N-terminal fragment with anti-Myc or the C-terminal fragment with anti-HOIP (Fig. 2D), and with the aid of caspase substrate prediction software (33), we identified Asp-348 and Asp-387 as putative caspase cleavage sites. Interestingly, whereas Asp-387 is conserved across mammalian species, Asp-348 is unique to primates (Fig. 3F). Individual mutation of either of these aspartates to glutamate caused a shift in the size of the HOIP fragments. In contrast, their com-bination resulted in a HOIP D348E/D387E mutant that was fully resistant to caspase-1 cleavage (Fig. 3G). These data demonstrate that HOIP is targeted by multiple caspases and is cleaved at Asp-348 and Asp-387.

HOIP cleavage limits NF-B and promotes cell death in keratinocytes
Many caspase substrates identified to date have little biological significance and represent bystander effects of apoptotic cell death (34). To determine whether the cleavage of HOIP had functional consequences, we examined its impact on LUBACinduced NF-B activation in HEK293T cells (Fig. 4A). Our results show that expression of WT caspase-1, but not a catalytically inactive C285A caspase-1 mutant, attenuated NF-Bdriven luciferase activity (Fig. 4B). Conversely, inhibition of caspase-1 enzymatic activity enhanced NF-B activity following UVB irradiation of HaCaT cells (Fig. 4C). To further probe for the functional impact of HOIP cleavage during apoptosis, we depleted endogenous HOIP from HaCaT cells using shRNA and stably reintroduced shRNA-resistant WT HOIP or the noncleavable D348E/D387E HOIP mutant. We found that cells expressing D348E/D387E HOIP had significantly enhanced expression of the NF-B-target genes IL6 and IL8 in response to TNF ϩ CHX stimulation compared with WT HOIP, whereas no differences were observed in response to TNF alone (Fig. 4,  D and E). These data suggest that NF-B signaling is attenuated during apoptosis in part due to HOIP cleavage. It has been

Regulation of caspase-1 and LUBAC activity in keratinocytes
shown that deficiency of HOIP renders a variety of cell types more sensitive to apoptotic cell death (21,35,36); thus, we wondered whether cleavage could also impact cell death. We first confirmed that HOIP deficiency in HaCaT cells enhanced TNF ϩ CHX-induced caspase-8 and -3 activation (Fig. 4F), similar to what we observed with UVB irradiation (Fig. 1, A and  B). Whereas introduction of WT HOIP attenuated cell death, particularly at early time points, D348E/D387E HOIP potently inhibited caspase activation at all time points studied (Fig. 4, F  and G). These data suggest that caspase-mediated cleavage of HOIP impairs LUBAC function in NF-B activation and in limiting apoptosis.

Caspase-mediated cleavage of HOIP impedes substrate ubiquitination by LUBAC
We found that caspase-1-mediated cleavage of HOIP did not affect the levels of total Met1-Ub (Fig. 5, A (compare lanes 4  and 5) and E (compare lanes 2 and 3)). Whereas these data suggest that caspase-mediated cleavage of HOIP does not affect general enzymatic function, it remains possible that targeting of specific LUBAC substrates may be affected. Asp-348 and Asp-387 are located between the Npl4 zinc finger 1 (NZF1) and NZF2 ubiquitin-binding domains in the N terminus of HOIP (Fig. 5B). Caspase targeting of these two residues separates the N-terminal PNGase/UBA or UBX-containing proteins (PUB), zinc finger (ZF), and NZF1 domains from the C-terminal fragment containing the Ub-associated (UBA) domain, the RING-in between-RING (RBR) domain, and the linear ubiquitin chain-determining domain (LDD), which dictate catalytic function. Whereas the PUB domain interacts with deubiquitinases to control LUBAC-dependent signaling (37)(38)(39), the UBA domain is necessary for Sharpin and HOIL-1 binding (40). Subcloning of the N-and C-terminal HOIP cleavage fragments revealed that C-HOIP retained the ability to interact with both Sharpin and HOIL-1 (Fig. 5C). Similarly, C-HOIP was able to generate linear ubiquitin chains when co-expressed with HOIL-1, whereas N-HOIP displayed no enzymatic activity (Fig. 5D). To examine whether caspase cleavage of HOIP affected LUBAC-mediated substrate modification, we examined NEMO Met1-Ub as a surrogate readout. Indeed, caspase-1-mediated cleavage of HOIP reduced Met1-Ub of NEMO (Fig. 5E, lanes 5 and 6). Of note, whereas caspase-1 did not affect total Met1-Ub in the absence of NEMO (Fig. 5E, lanes 2  and 3), there was a slight reduction in total Met1-Ub caused by caspase-1 upon overexpression of NEMO (lanes 5 and 6). Collectively, these data demonstrate that in keratinocytes, caspases promote cell death and inhibit NF-B activation by targeting HOIP for proteolytic cleavage, which may impede substrate ubiquitination by LUBAC.

Discussion
As the first line of defense against invading microorganisms and as a sensor of sterile tissue damage, the skin innate immune system plays a pivotal role in maintaining human health and homeostasis. As such, it has evolved extensive regulatory mechanisms to coordinate a response in duration and magnitude that ensures the elimination of the pathogen, initiation of tissue repair, and/or induction of adaptive immunity while minimizing bystander damage to the host. Pattern recognition receptors and cytokine receptors are key players in innate immunity that, when engaged, rapidly trigger a complex network of intracellular events that can lead to multiple distinct or overlapping signaling outcomes, depending on the cellular context. Here, we describe LUBAC-mediated inhibition of caspase-1 and reciprocal caspase-mediated inhibition of LUBAC as two regulatory checkpoints in keratinocytes that modulate inflammatory signaling and cell death.
Considering these data and our previous work (27), we propose the following model (Fig. 6). In WT keratinocytes, HOIP forms a constitutive interaction with caspase-1 and mediates the linear ubiquitination of its CARD pro-domain. Upon engagement of apoptosis, caspase-1 and caspase-8 cleave HOIP at Asp-348 and Asp-387, limiting the ability of LUBAC to ubiquitinate substrates. This results in attenuated NF-Bdependent gene expression and enhanced cell death. Activation of apoptosis in the absence of LUBAC leads to enhanced caspase-1, -3, and -8 activity, promoting pathology in vivo, such as the dermatitis observed in Cpdm mice. It is tempting to speculate that LUBAC directly inhibits caspase-1 activity via linear ubiquitination; however, this remains to be tested empirically. The identification of the lysine residue(s) targeted by LUBAC and subsequent examination of the activity of a nonubiquitinatable caspase-1 mutant will be necessary to test this hypothesis.

Regulation of caspase-1 and LUBAC activity in keratinocytes
was shown that release of C-HOIL-1 from LUBAC leads to HOIP destabilization and degradation by the proteasome (41). When overexpressed in HEK293T cells, C-HOIL-1 antagonized LUBAC function and NF-B activity (41,42). Further, activation of lymphocytes with either phorbol 12-myristate 13-acetate (PMA)/ionomycin or anti-CD3/CD28 leads to a rapid decrease in total Met1-Ub levels in WT cells but not those expressing a catalytically inactive MALT1 mutant (41). One group noted a reduction in NF-B activation upon overexpression of HOIL-1 in Jurkat T-cells, which was more pronounced when cells expressed the noncleavable mutant (43). Given the variation in experimental design between these reports, it will be important to dissect the functional role of HOIL-1 cleavage by MALT1 by reconstitution of HOIL-1deficient B/T-cells with the noncleavable mutant. Of note, the deubiquitinase CYLD, which regulates LUBAC function (44,45), is cleaved by both MALT1 and caspase-8, highlighting a common theme of regulation of the Met1-Ub machinery by caspases. HOIP has also been described to be cleaved in a variety of cell types during apoptosis (46 -48). Joo et al. (46) found that caspase-3 and -6, but not caspase-1 or -8, cleaved HOIP at Asp-348, Asp-387, and Asp-390, and reconstitution of HOIP-deficient Jurkat T-cells with a triple mutant HOIP slightly attenuated TNF-induced apoptosis (46). They observed that although C-HOIP retained enzymatic activity and could target RIPK1 and NEMO with Met1-Ub, it was unable to induce NF-B activation in parallel overexpression assays. Goto et al. (47) identified Asp-390 as the primary HOIP cleavage site, which likewise enhanced resistance to apoptosis when mutated to glutamate in Jurkat T cells. Unlike Joo et al. (46), they found that C-HOIP is capable of triggering substrate ubiquitination and NF-B activation as effectively as full-length HOIP. Nevertheless, they found that substrate Met1-Ub decreases during apoptosis, which was attributed to HOIP cleavage. Lafont et al. (48) reported TRAIL-induced HOIP cleavage, predominantly by caspase-8, which can be blocked by mutating Asp-348, Asp-387, and Asp-390. Interestingly, preventing HOIP cleavage had no effect on TRAIL-induced cell death in K562 cells, a myelogenous leukemic cell line. Thus, to date, the functional outcome of HOIP cleavage has only been examined in HEK293T cells and lymphocyte cell lines. The role of LUBAC in cell death and inflammatory signaling varies between cell types (14,15,17,20); for example, unlike keratinocytes (24,25,36), LUBAC activity does not limit TNF-induced cell death of primary murine T cells (49). Given the role of LUBAC in mitigating skin inflammation and keratinocyte cell death in vivo (23,36), we chose to study HaCaT keratinocytes as a relevant model for examining the regulation of LUBAC activity. In these cells, we found that cleavage of HOIP promoted apoptosis and limited NF-B activity.
It was previously reported that caspase-1 is upstream of apoptotic caspases in UVB-induced cell death of keratinocytes (50). Further, transgenic overexpression of caspase-1 in murine keratinocytes drives massive cutaneous apoptosis and inflammatory skin disease (51). Here, we report that inhibition or silencing of caspase-1 attenuates apoptotic caspase activation downstream of multiple apoptotic triggers in keratinocytes. Thus, whereas the regulation of LUBAC activity and apoptosis by caspase-1 is consistent with the literature, it remains possible that caspase-1 acts indirectly on HOIP through apoptotic caspases. In fact, caspase-1 showed no capacity to process HOIP in previous studies (46 -48); this, however, may be in part due to technical differences. Whereas we have used ITT HOIP to examine susceptibility to cleavage by recombinant caspases, Joo et al. (46) and Lafont et al. (48) used immunoprecipitated HOIP from HEK293T cells. These differences may impact caspase sensitivity due to co-precipitation of inhibitory cofactors or endogenous post-translational modifications of HOIP that might prevent its cleavage. Nevertheless, using recombinant proteins, overexpression, pharmacological inhibition, and stable genetic silencing, we found that caspase-1 and caspase-8 cleaved HOIP in response to apoptotic triggers. We observed that inhibition of caspase-1 enhanced NF-B activity and cytokine production downstream of UVB irradiation, consistent with restored LUBAC function. Interestingly, inhibition of caspase activity revealed the NF-Bdependent pro-inflammatory and anti-tumorigenic effects of mitochondrial outer membrane permeabilization in vitro and in vivo (52). As mitochondrial outer membrane permeabilization also occurs following UVB irradiation (53), it is tempting to speculate that these reported effects may be in part driven by LUBAC. Indeed, LUBAC has been shown to regulate genotoxic stress-driven NF-B activation (e.g. following UVB-induced DNA damage) through the linear ubiquitination of NEMO (54).
Using overexpression assays, we identified caspase-1 as a putative LUBAC substrate. In bone marrow-derived macrophages, caspase-1 is modified with polyubiquitin chains of unknown topology following activation of the NLRP1B inflammasome with anthrax lethal toxin (55). As NLRP1 is also the sensor of UVB irradiation in keratinocytes (56), this suggests that LUBAC may play specific roles downstream of NLRP1. Indeed, LUBAC has been shown to target the adaptor ASC with Met1-Ub, which, through an unknown mechanism, promotes

Regulation of caspase-1 and LUBAC activity in keratinocytes
inflammasome activation (3). NLRP1, however, possesses a CARD domain, allowing it to bypass ASC and directly bind to and activate caspase-1 (55), supporting the idea that LUBAC may have a distinct inhibitory role in the regulation of the NLRP1 inflammasome. Collectively, these findings expand on the extensive and dynamic regulatory network within innate immunity pathways that control inflammation and cell death signaling.

Cell lines
HaCaT cells and THP-1 monocytes were cultured in RPMI ϩ 10% FBS ϩ L-glutamine ϩ penicillin/streptomycin, and HEK293T cells were cultured in Dulbecco's modified Eagle's medium ϩ 10% FBS ϩ L-glutamine. All cell lines were treated with mycoplasma removal agent for 10 days prior to expansion and freezing.

Cell stimulations
Stimulations were performed in serum-free Opti-MEM. All inhibitors were added at least 30 min prior to the addition of TNF␣. UVB irradiation was performed using a Transilluminator at 80% intensity. Briefly, medium was removed, and cells were washed with warm PBS. Cells were exposed to direct UVB light for 15 s (equivalent to 50 mJ/cm 2 ) before medium was added back for the indicated times. Caspase-1 and caspase-8 activity was measured using the Caspase Glo-1 (Promega G9951) and Caspase Glo-8 assays (Promega G8201) according to the manufacturer's protocol. Cell viability was measured using the CellTiter-Glo luminescent cell viability assay (Promega G7570) according to the manufacturer's instructions.
THP-1 monocytes were differentiated overnight using PMA. The following day, medium was replaced with serum-free Opti-MEM, and cells were primed using 100 ng/ml LPS for 4 h before the addition of ATP (5 mM, 1 h), Lipofectamine-transfected poly(dA:dT) (1.5 g/ml, 6 h), or DOTAP-transfected flagellin (2.0 g/ml, 6 h). Cells were harvested and lysed in Laemmli buffer, and protein content was precipitated from cell-free supernatants using TCA/acetone, resuspended in 2ϫ loading buffer for immunoblotting.
Membranes were stained with Ponceau S Red before being dried and blocked with either 4% BSA or 5% nonfat dry milk in TBS ϩ 0.1% Tween 20 (TBS-T) for 1 h at room temperature. Membranes were incubated with primary antibody overnight and washed three times for 10 min each with 0.1% TBS-T, and secondary antibody was added for 1 h at room temperature.
Following another round of washes, proteins were visualized using enhanced chemiluminescence.
For immunoprecipitation (IP) of FLAG-tagged proteins, cells were washed with ice-cold PBS lysed in ice-cold lysis buffer (1% Triton, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA) supplemented with 10 mM sodium fluoride, 1 mM sodium orthovanadate, 10 mM ␤-glycerophosphate, and complete protease inhibitors (Roche Applied Science) and left on ice for 30 -60 min, followed by three 15-s bouts of sonication at 65% amplitude. Lysates were centrifuged at 13,000 rpm for 20 min, soluble proteins were collected, and protein concentration was quantified using the Bio-Rad DC Assay. The FLAG M2 affinity gel was washed two times with TBS before a 20-l packed volume of beads was added to each IP sample. Samples were rotated at 4°C for 2 h and washed three times with lysis buffer and one time with PBS, and proteins were eluted by boiling in 40 l of 2ϫ loading buffer. For immunoprecipitation of HA, Sharpin, or caspase-1, lysates were processed as above, and 2 g of antibody was added to 0.5-1 mg of lysate and rotated overnight at 4°C. The next day, a 20-l packed volume of washed Protein G-agarose was added to each IP sample and rotated for an additional 3-4 h. Samples were then washed and eluted as above.

Immunoblotting and immunoprecipitations
Following stimulation, HaCaT cells were scraped into the media and collected on ice. Cells were pelleted by centrifugation, washed with ice-cold PBS, and then lysed in Laemmli buffer and sonicated 3 times for 15 s each at 70% amplitude. Lysates were boiled for 5 min at 95°C, and an aliquot was used for SDS-PAGE and transferred to nitrocellulose by wet transfer in 10 -20% methanol transfer buffer.
When studying linear ubiquitination, cells were resuspended in Ub lysis buffer (1% SDS, 50 mM Tris-HCl, pH 7.5, 5 mM EDTA) supplemented with complete protease inhibitors and 20 mM N-ethylmaleimide and boiled for 15 min at 95°C. Lysates

Regulation of caspase-1 and LUBAC activity in keratinocytes
were diluted 10 times with Buffer G (1% Triton, 50 mM Tris-HCl, pH 7.5) supplemented with N-ethylmaleimide and protease inhibitors and mechanically lysed with a 23-gauge syringe. Lysates were centrifuged at 13,000 rpm for 20 min, soluble proteins were collected, and protein concentration was quantified using the Bio-Rad DC assay. Immunoprecipitations were carried out as above.

RT-PCR
RNA was extracted using the RNeasy MINI kit (Qiagen 74104) according to the manufacturer's protocol. 1.0 g of RNA was reverse-transcribed into cDNA using random hexamers and Moloney murine leukemia virus reverse transcriptase in a total volume of 20 l, according to the manufacturers' protocol. Quantitative PCR was performed using iTaq SYBR Green supermix, and following normalization to the housekeeping gene RPL32, -fold induction over untreated was calculated using the 2 Ϫ⌬⌬Ct method.

Plasmids, cloning, and mutagenesis
All shRNA plasmids were obtained from the MISSION shRNA library (Sigma-Aldrich) via McGill University. All mutations were performed using the QuikChange Lightning kit (Agilent Technologies 210518) according to the manufacturer's protocol. Subcloning of Myc-HOIP constructs into pLenti-CMV-Blast (Addgene 17486) for reconstitution experiments was performed using the In-Fusion HD Cloning kit (Takara Bio 121416)

Luciferase assay
NF-Bdriven luciferase activity was measured using the Luciferase Reporter Gene Detection Kit (Sigma LUC1) according to the manufacturer's protocol.

In vitro transcription and translation
In vitro transcribed and translated recombinant proteins were synthesized using the Promega TNT Quick Coupled Transcription/Translation System (Promega L1170) using 1 g of plasmid according to the manufacturer's protocol. 2 l of reaction product was incubated in CHEGG buffer (50 mM HEPES-KOH, 100 mM NaCl, 2 mM EDTA, 0.10% CHAPS, 10% glycerol, 10 mM DTT) containing 2 units of recombinant caspase (Biovision K233) and incubated at 37°C for 1 h. The reaction was terminated by the addition of Laemmli buffer, and cleavage events were analyzed by immunoblotting.

Lentiviral transduction
3 ϫ 10 5 HEK293T cells were seeded on poly-L-lysine-coated 6-well plates in 2 ml of Dulbecco's modified Eagle's medium ϩ 10% FBS. The following day, cells were transfected with 1.5 g of psPAX2, 0.5 g of pMD2.G, and 2.0 of g of shRNA or pLenti constructs for reconstitution using Lipofectamine 2000. 24 h later, medium was collected and stored at 4°C, and 3 ml of fresh medium was added to cells. The following day, medium was collected, pooled with the 24-h sample, and centrifuged at 2000 rpm for 10-min to pellet cells and debris. 4 ml of virus-containing medium was added to HaCaT cells in 10-cm dishes at 30% confluence and supplemented with penicillin-streptomycin and 8 g/ml Polybrene. Viral medium was left on for 8 h at 37°C before cells were washed and replaced with fresh RPMI ϩ 10% FBS ϩ L-glutamine ϩ penicillin/streptomycin for an additional 16 h. Medium was replaced again at 24 h post-transduction, and cells were selected 48 h post-transduction with 2 g/ml puromycin (for shRNA) or 10 g/ml blasticidin (for reconstitution) for 10 days.

Statistical analysis
Data are represented as the mean Ϯ S.E. Two-tailed Student's t test was used for evaluating statistical significance between two groups. One-way analysis of variance followed by a Bonferroni post-hoc comparison test was used to evaluate statistical significance among three or more groups. *, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001.

Data availability
All data are contained within this paper.